These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 37429175)

  • 21. Increased Protein Kinase A Activity Induces Fibrolamellar Hepatocellular Carcinoma Features Independent of DNAJB1.
    Shirani M; Levin S; Shebl B; Requena D; Finkelstein TM; Johnson DS; Ng D; Lalazar G; Heissel S; Hojrup P; Molina H; de Jong YP; Rice CM; Singhi AD; Torbenson MS; Coffino P; Lyons B; Simon SM
    Cancer Res; 2024 Aug; 84(16):2626-2644. PubMed ID: 38888469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rare variants of primary liver cancer: Fibrolamellar, combined, and sarcomatoid hepatocellular carcinomas.
    Wege H; Schulze K; von Felden J; Calderaro J; Reig M;
    Eur J Med Genet; 2021 Nov; 64(11):104313. PubMed ID: 34418585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A framework for fibrolamellar carcinoma research and clinical trials.
    Dinh TA; Utria AF; Barry KC; Ma R; Abou-Alfa GK; Gordan JD; Jaffee EM; Scott JD; Zucman-Rossi J; O'Neill AF; Furth ME; Sethupathy P
    Nat Rev Gastroenterol Hepatol; 2022 May; 19(5):328-342. PubMed ID: 35190728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fibrolamellar hepatocellular carcinoma at a tertiary centre in South Africa: a case series.
    Bhaijee F; Locketz ML; Krige JE
    S Afr J Surg; 2009 Nov; 47(4):108-11. PubMed ID: 20141066
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fibrolamellar hepatocellular carcinoma.
    Liu S; Chan KW; Wang B; Qiao L
    Am J Gastroenterol; 2009 Oct; 104(10):2617-24; quiz 2625. PubMed ID: 19638962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibrolamellar Carcinoma: Recent Advances and Unresolved Questions on the Molecular Mechanisms.
    Lalazar G; Simon SM
    Semin Liver Dis; 2018 Feb; 38(1):51-59. PubMed ID: 29471565
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DNAJB1-PRKACA is specific for fibrolamellar carcinoma.
    Graham RP; Jin L; Knutson DL; Kloft-Nelson SM; Greipp PT; Waldburger N; Roessler S; Longerich T; Roberts LR; Oliveira AM; Halling KC; Schirmacher P; Torbenson MS
    Mod Pathol; 2015 Jun; 28(6):822-9. PubMed ID: 25698061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combined hepatocellular carcinoma and cholangiocarcinoma: clinical features, treatment modalities, and prognosis.
    Yin X; Zhang BH; Qiu SJ; Ren ZG; Zhou J; Chen XH; Zhou Y; Fan J
    Ann Surg Oncol; 2012 Sep; 19(9):2869-76. PubMed ID: 22451237
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alternative lengthening of telomeres in primary hepatic neoplasms.
    Yasir S; Thompson S; Chen ZE; Knudson R; Knutson D; Kloft-Nelson S; Graham RP; Jain D; Simon SM; Wu TT; Torbenson M
    Hum Pathol; 2023 Jan; 131():79-86. PubMed ID: 36370823
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined hepatocellular-cholangiocarcinoma: a clinicopathological study.
    Ng IO; Shek TW; Nicholls J; Ma LT
    J Gastroenterol Hepatol; 1998 Jan; 13(1):34-40. PubMed ID: 9737569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Successful Liver Transplantation of Recurrent Fibrolamellar Carcinoma following Clinical and Pathologic Complete Response to Triple Immunochemotherapy: A Case Report.
    Kang S; Magliocca J; Sellers M; Roccaro G; Zheng W; Pectasides M; Draper A; Guadagno J; El-Rayes B; Akce M
    Oncol Res Treat; 2022; 45(7-8):430-437. PubMed ID: 35537414
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis.
    Sia D; Villanueva A; Friedman SL; Llovet JM
    Gastroenterology; 2017 Mar; 152(4):745-761. PubMed ID: 28043904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognosis of fibrolamellar carcinoma versus conventional hepatocellular carcinoma: a study based on propensity score matching.
    Qiu S; Chen R; Hu J; Han T
    Scand J Gastroenterol; 2023; 58(11):1351-1358. PubMed ID: 37353942
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocellular carcinoma with both fibrolamellar and classical components: an unusual morphological pattern.
    Castro-Villabón D; Barrera-Herrera LE; Rodríguez-Urrego PA; Hudacko R; Vera A; Álvarez J; Andrade R; López R
    Case Rep Pathol; 2015; 2015():609780. PubMed ID: 25815229
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma.
    Bauer J; Köhler N; Maringer Y; Bucher P; Bilich T; Zwick M; Dicks S; Nelde A; Dubbelaar M; Scheid J; Wacker M; Heitmann JS; Schroeder S; Rieth J; Denk M; Richter M; Klein R; Bonzheim I; Luibrand J; Holzer U; Ebinger M; Brecht IB; Bitzer M; Boerries M; Feucht J; Salih HR; Rammensee HG; Hailfinger S; Walz JS
    Nat Commun; 2022 Oct; 13(1):6401. PubMed ID: 36302754
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fibrolamellar Hepatocellular Carcinoma: Comprehensive Review of Diagnosis, Imaging, and Management.
    Aziz H; Brown ZJ; Panid Madani S; Kamel IR; Pawlik TM
    J Am Coll Surg; 2023 Feb; 236(2):399-410. PubMed ID: 36648268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Long Non-Coding RNA Profiles and Potential Therapeutic Agents for Fibrolamellar Carcinoma Based on RNA-Sequencing Data.
    Kim J; Kim Y; Lee B
    Genes (Basel); 2023 Aug; 14(9):. PubMed ID: 37761849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Primary Liver Cancers - Hepatocellular Carcinoma and Cholangiocarcinoma].
    Soysal SD; Kollmar O
    Ther Umsch; 2021; 78(10):585-588. PubMed ID: 34844438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Update on the pathology of liver neoplasms.
    Matsukuma KE; Yeh MM
    Ann Diagn Pathol; 2019 Feb; 38():126-137. PubMed ID: 30597357
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The alphavbeta6 integrin is a highly specific immunohistochemical marker for cholangiocarcinoma.
    Patsenker E; Wilkens L; Banz V; Osterreicher CH; Weimann R; Eisele S; Keogh A; Stroka D; Zimmermann A; Stickel F
    J Hepatol; 2010 Mar; 52(3):362-9. PubMed ID: 20137822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.